Vaccine development can be really expensive, and there’s limited commercial return.
Articles on Genetic material
Displaying all articles
South Africa’s recently updated research ethics guidelines provide guidance on oversight into heritable human genome editing, and they should not be interpreted as a green light.
Just as the world’s zoos breed critically endangered animals in captivity to repopulate the wild, scientists are building a global effort to freeze corals for reef restoration.
Evidence is mounting for links to animals at the Wuhan wet market. But we’ve wasted a lot of time and energy getting here.
Making sure RNA molecules are in the right place at the right time in a cell is critical to development and normal function. Researchers are figuring out exactly how they get to where they need to go.
In 2030, there is a boom in precision medicine, where diseases – from cancer to dementia – are defined and targeted more specifically with a focus on their molecular makeup.
One big challenge for gene therapies is delivering DNA or RNA safely to cells inside patients’ bodies. New nanoparticles could be an improvement over the current standard – repurposed viruses.
Top contributors
-
Professor, Central Clinical School, Monash University
-
Doctoral Student in Biochemistry, University of Washington
-
Public Health Pathology, NSW Health Pathology, Westmead Hospital and University of Sydney, University of Sydney
-
Research Scientist, Smithsonian Institution
-
Assistant Professor of Biochemistry and Molecular Genetics, University of Colorado Anschutz
-
Fellow, Center for Law and the Biosciences, Stanford University
-
Calleva Head of Vaccine Immunology, University of Oxford
-
PhD Candidate, Paediatrics, University of Oxford
-
Postdoctoral Researcher, Oxford Vaccine Group, University of Oxford